Why Are Angiotensin converting Enzyme Inhibitors Effective in Myocardial ischaemia?
Main Article Content
W know what we are but we know not what we may be shakespear (Ophellia, in halmet). Newer indications are being added to the condition benefiting from Angiotensin converting enzyme inhibitors. They have an extremely success ful track record for lowering systolic and diastolic blood pressure and have been employed usefully in the setting of symptomatic and asymptomatic cardiac failure and post myocardial infarction. Their new role of possessing antischaemic properties has come to limelight only recently. This article reviews the evidence and the possible mechanisms for it.
How to Cite
Hafizullah M. Why Are Angiotensin converting Enzyme Inhibitors Effective in Myocardial ischaemia?. J Postgrad Med Inst [Internet]. 2011 Sep. 27 [cited 2023 Mar. 24];18(1). Available from: https://www.jpmi.org.pk/index.php/jpmi/article/view/866
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.